Barbora, M. (2023). Engineering Escherichia coli for hyper-production of outer membrane vesicles enriched in heterologous lipidated antigens for use as a novel mucosal vaccine platform.
Chicago Style (17th ed.) CitationBarbora, Martinkova. Engineering Escherichia Coli for Hyper-production of Outer Membrane Vesicles Enriched in Heterologous Lipidated Antigens for Use as a Novel Mucosal Vaccine Platform. 2023.
MLA (9th ed.) CitationBarbora, Martinkova. Engineering Escherichia Coli for Hyper-production of Outer Membrane Vesicles Enriched in Heterologous Lipidated Antigens for Use as a Novel Mucosal Vaccine Platform. 2023.
Warning: These citations may not always be 100% accurate.